NanoViricides
NNVC
31 hedge funds and large institutions have $1.47M invested in NanoViricides in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 3 closing their positions.
67% more call options, than puts
Call options by funds: $5K | Put options by funds: $3K
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
3% more funds holding
Funds holding: 30 → 31 (+1)
0.98% less ownership
Funds ownership: 11.75% → 10.77% (-0.98%)
3% less capital invested
Capital invested by funds: $1.51M → $1.47M (-$45K)
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$19.1K |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
+$15.5K |
| 3 |
TWP
TFO Wealth Partners
Maumee,
Ohio
|
+$72 |
| 4 |
CSPIA
Cary Street Partners Investment Advisory
Richmond,
Virginia
|
+$20 |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$98.5K |
| 2 |
Millennium Management
New York
|
-$18.3K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$14.9K |
| 4 |
VF
Virtu Financial
New York
|
-$13K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$10.5K |
NNVC Hedge Fund Activity: Q1 2023 in Review
31 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q1 2023, worth a combined $1.47M — down 3% from $1.51M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NNVC positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 7 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $19.1K. The largest seller was Citadel Advisors, cutting an estimated $98.5K.
- 31 institutional investors held NanoViricides (NNVC) as of Q1 2023, up from 30 in Q4 2022.
- Funds reported $1.47M of NanoViricides stock for Q1 2023, down 3% quarter-over-quarter.
- 4 funds opened new NanoViricides positions in Q1 2023 and 3 closed out, a net change of +1 holder.
- The largest NanoViricides buyer in Q1 2023 was Susquehanna International Group, an estimated $19.1K added.
- The largest NanoViricides seller in Q1 2023 was Citadel Advisors, an estimated $98.5K sold.
Based on aggregated 13F filings for Q1 2023.